MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,040,199 | -82.0% | 149,859 | -88.0% | 0.00% | -83.3% |
| Q3 2022 | $22,391,000 | +39.4% | 1,246,705 | -3.5% | 0.01% | +50.0% |
| Q2 2022 | $16,057,000 | +37.9% | 1,291,796 | +47.8% | 0.00% | +100.0% |
| Q1 2022 | $11,645,000 | +34.8% | 874,189 | +57.5% | 0.00% | 0.0% |
| Q4 2021 | $8,640,000 | -27.9% | 554,920 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $11,985,000 | +3.0% | 534,048 | +4.5% | 0.00% | 0.0% |
| Q2 2021 | $11,635,000 | +7.4% | 510,997 | -2.9% | 0.00% | 0.0% |
| Q1 2021 | $10,835,000 | -43.7% | 526,481 | -24.5% | 0.00% | -60.0% |
| Q4 2020 | $19,257,000 | +310.1% | 697,175 | +108.6% | 0.01% | – |
| Q3 2020 | $4,696,000 | -66.9% | 334,227 | -51.5% | 0.00% | -100.0% |
| Q2 2020 | $14,206,000 | +288.2% | 688,951 | +42.1% | 0.01% | +400.0% |
| Q1 2020 | $3,659,000 | +13.5% | 484,758 | +133.4% | 0.00% | 0.0% |
| Q4 2019 | $3,224,000 | +655.0% | 207,723 | +152.8% | 0.00% | – |
| Q3 2019 | $427,000 | -76.0% | 82,158 | -58.1% | 0.00% | -100.0% |
| Q2 2019 | $1,776,000 | – | 196,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |